The Future of Medical Research & Development for Cardiovascular Care —Global Harmonization to Establish an Ecosytem for Medical Innovation—

One of the three big arrows of “Abenomics”, AMED (Japan Agency for Medical Research and Development) was established in April, 2015.
Under the mission to utilize basic research for the improvement of health, medical quality, and industrialization, it started to support hopeful research with management from results to practical uses.
In addition, construction of a system for product development which includes launching a new venture business to utilize research results for industrialization, has been initiated in various places in Japan, like local governments, where each ministry agency is in the center.
However, U.S.A., Israel, and other Asian countries, as well as Japan make desperate efforts to industrialize research results speedily and efficiently and to launch a worldwide medical innovation. Japan does not have enough time to hesitate.
As we are faced with the worst super-aging society in history, it is important for us to promote Japan's medical research, its industrialization, and to develop medical innovation not only within a country but also in the world, as a responsibility of cardiologists.
I expect that it will make the Japanese economy which has slowed down revive.
To achieve it, I think that the strategies in medical research and industrialization for a goal of worldwide development are important. It is also necessary to construct an ecosystem for the worldwide medical research and development, not only in the country but also in the world, beyond a boundary among industry, university and government.
This time, I hope that we could have a hot discussion about medical research and development with focusing on expanding overseas in the field of Cardiovascular in Japan.